26394756|t|QIAD assay for quantitating a compound's efficacy in elimination of toxic Abeta oligomers.
26394756|a|Strong evidence exists for a central role of amyloid beta-protein (Abeta) oligomers in the pathogenesis of Alzheimer's disease. We have developed a fast, reliable and robust in vitro assay, termed QIAD, to quantify the effect of any compound on the Abeta aggregate size distribution. Applying QIAD, we studied the effect of homotaurine, scyllo-inositol, EGCG, the benzofuran derivative KMS88009, ZAbeta3W, the D-enantiomeric peptide D3 and its tandem version D3D3 on Abeta aggregation. The predictive power of the assay for in vivo efficacy is demonstrated by comparing the oligomer elimination efficiency of D3 and D3D3 with their treatment effects in animal models of Alzheimer s disease. 
26394756	74	79	Abeta	Gene	351
26394756	158	163	Abeta	Gene	351
26394756	198	217	Alzheimer's disease	Disease	MESH:D000544
26394756	340	345	Abeta	Gene	351
26394756	415	426	homotaurine	Chemical	MESH:C001355
26394756	428	443	scyllo-inositol	Chemical	MESH:C009217
26394756	445	449	EGCG	Chemical	MESH:C045651
26394756	455	465	benzofuran	Chemical	MESH:C105430
26394756	477	485	KMS88009	Chemical	-
26394756	487	495	ZAbeta3W	Chemical	-
26394756	524	526	D3	Chemical	MESH:D002762
26394756	550	554	D3D3	Chemical	-
26394756	558	563	Abeta	Gene	351
26394756	700	702	D3	Chemical	MESH:D002762
26394756	707	711	D3D3	Chemical	-
26394756	761	780	Alzheimer s disease	Disease	MESH:D000544
26394756	Negative_Correlation	MESH:D002762	MESH:D000544
26394756	Negative_Correlation	MESH:C105430	351
26394756	Negative_Correlation	MESH:C045651	351
26394756	Negative_Correlation	MESH:C001355	351
26394756	Association	MESH:D000544	351
26394756	Negative_Correlation	MESH:D002762	351
26394756	Negative_Correlation	MESH:C009217	351

